PharmaSynth Overview
- Founded
-
2008
- Status
-
Acquired/Merged
- Employees
-
18
- Latest Deal Type
-
M&A
- Financing Rounds
-
1
PharmaSynth General Information
Description
Provider of contract manufacturing services. The company offers manufacturing of recombinant proteins and vaccines, microbial products, fermentation optimization, downstream processing and related services in Australia.
Contact Information
Website
www.pharmasynth.com.au
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Other Commercial Services
Other Industries
Pharmaceuticals
Other Pharmaceuticals and Biotechnology
Acquirer
Primary Office
- 2806 Ipswich Road
- Darra, Queensland 4076
- Australia
+61 (07) 0000 0000
PharmaSynth Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
PharmaSynth Executive Team (1)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Leslie Tillack | Chief Executive Officer & Director |
PharmaSynth Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PharmaSynth Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|